» Articles » PMID: 30288418

Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized Data

Overview
Publisher Sage Publications
Specialty General Medicine
Date 2018 Oct 6
PMID 30288418
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Propensity score (PS) methods are frequently used within economic evaluations based on nonrandomized data to adjust for measured confounders, but many researchers omit the fact that they cannot adjust for unmeasured confounders. To illustrate how confounding due to unmeasured confounders can bias an economic evaluation despite PS matching. We used data from a previously published nonrandomized study to select a prematched population consisting of 121 patients (46.5%) who received endovascular aneurysm repair (EVAR) and 139 patients (53.5%) who received open surgical repair (OSR), in which sufficient data regarding eight measured confounders were available. One-to-one PS matching was used within this population to select two PS-matched subpopulations. The Matched PS-Smoking Excluded Subpopulation was selected by matching patients using a PS model that omitted patients' smoking status (one of the measured confounders), whereas the Matched PS-Smoking Included Subpopulation was selected by matching patients using a PS model that included all eight measured confounders. Incremental cost-effectiveness ratios (ICERs) were assessed within both subpopulations. Both subpopulations were composed of two different sets of 164 patients. Balance within the Matched PS-Smoking Excluded Subpopulation was achieved on all confounders except for patients' smoking status, whereas balance within the Matched PS-Smoking Included Subpopulation was achieved on all confounders. Results indicated that the ICER of EVAR over OSR differed between both subpopulations; the ICER was estimated at $157,909 per life-year gained (LYG) within the Matched PS-Smoking Excluded Subpopulation, while it was estimated at $235,074 per LYG within the Matched PS-Smoking Included Subpopulation. Although effective in controlling for measured confounding, PS matching may not adjust for unmeasured confounders that may bias the results of an economic evaluation based on nonrandomized data.

Citing Articles

Real World Data in Health Technology Assessment of Complex Health Technologies.

Hogervorst M, Ponten J, Vreman R, Mantel-Teeuwisse A, Goettsch W Front Pharmacol. 2022; 13:837302.

PMID: 35222045 PMC: 8866967. DOI: 10.3389/fphar.2022.837302.

References
1.
DAgostino Jr R . Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17(19):2265-81. DOI: 10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b. View

2.
Tarride J, Blackhouse G, De Rose G, Bowen J, Nakhai-Pour H, OReilly D . Should endovascular repair be reimbursed for low risk abdominal aortic aneurysm patients? Evidence from ontario, Canada. Int J Vasc Med. 2011; 2011:308685. PMC: 3124872. DOI: 10.1155/2011/308685. View

3.
DAgostino Jr R, DAgostino Sr R . Estimating treatment effects using observational data. JAMA. 2007; 297(3):314-6. DOI: 10.1001/jama.297.3.314. View

4.
Kreif N, Grieve R, Zia Sadique M . Statistical methods for cost-effectiveness analyses that use observational data: a critical appraisal tool and review of current practice. Health Econ. 2012; 22(4):486-500. DOI: 10.1002/hec.2806. View

5.
Austin P, Mamdani M . A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med. 2005; 25(12):2084-106. DOI: 10.1002/sim.2328. View